| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 57 |
| 1 | CISPLATIN | 55 |
| 2 | BLEOMYCIN SULFATE | 46 |
| 3 | BLEOMYCIN | 44 |
| 4 | IBUPROFEN | 9 |
| 5 | IFOSFAMIDE | 9 |
| 6 | IFOSFAMIDE FOR INJECTION | 9 |
| 7 | LEVETIRACETAM | 9 |
| 8 | NAPROXEN | 9 |
| 9 | NAPROXEN SODIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLEOMYCIN SULFATE | 46 | 0.0044 |
| 1 | CYCLOSERINE | 3 | 0.0013 |
| 2 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 3 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 4 | ETOPOSIDE | 57 | 0.0008 |
| 5 | CISPLATIN | 55 | 0.0007 |
| 6 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 7 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| 8 | AMPICILLIN INJECTION | 4 | 0.0005 |
| 9 | DESMOPRESSIN ACETATE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 58 |
| 1 | Topoisomerase Inhibitor [EPC] | 57 |
| 2 | Corticosteroid [EPC] | 24 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 4 | Benzodiazepine [EPC] | 14 |
| 5 | Alkylating Drug [EPC] | 11 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 7 |
| 8 | Atypical Antipsychotic [EPC] | 6 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 57 | 0.0007 |
| 1 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 3 | Platinum-based Drug [EPC] | 58 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 9 | Oxazolidinone Antibacterial [EPC] | 3 | 0.0001 |